Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen

por Jager, N. G. L., Rosing, H., Linn, S. C., Schellens, J. H. M., Beijnen, J. H.
Publicado 2012

Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation

por Hendrikx, J J M A, Lagas, J S, Wagenaar, E, Rosing, H, Schellens, J H M, Beijnen, J H, Schinkel, A H
Publicado 2014

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor.

por Schellens, J. H., Creemers, G. J., Beijnen, J. H., Rosing, H., de Boer-Dennert, M., McDonald, M., Davies, B., Verweij, J.
Publicado 1996

Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients

por van Andel, L., Rosing, H., Zhang, Z., Hughes, L., Kansra, V., Sanghvi, M., Tibben, M. M., Gebretensae, A., Schellens, J. H. M., Beijnen, J. H.
Publicado 2017

Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a (14)C-microtracer and therapeutic dose in cancer patients

por van Andel, L., Rosing, H., Zhang, Z., Hughes, L., Kansra, V., Sanghvi, M., Tibben, M. M., Gebretensae, A., Schellens, J. H. M., Beijnen, J. H.
Publicado 2017

Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients

por Malingré, M M, Beijnen, J H, Rosing, H, Koopman, F J, Jewell, R C, Paul, E M, Huinink, W W Ten Bokkel, Schellens, J H M
Publicado 2001

Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection

por Kip, A. E., Rosing, H., Hillebrand, M. J. X., Blesson, S., Mengesha, B., Diro, E., Hailu, A., Schellens, J. H. M., Beijnen, J. H., Dorlo, T. P. C.
Publicado 2016

Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen

por van Nuland, M., Vreman, R. A., ten Ham, R. M. T., de Vries Schultink, A. H. M., Rosing, H., Schellens, J. H. M., Beijnen, J. H., Hövels, A. M.
Publicado 2018

Oral topotecan: bioavailability and effect of food co-administration

por Herben, V M M, Rosing, H, Huinink, W W ten Bokkel, Zomeren, D M van, Batchelor, D, Doyle, E, Beusenberg, F D, Beijnen, J H, Schellens, J H M
Publicado 1999

The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients

por Malingré, M M, Schellens, J H M, Tellingen, O Van, Ouwehand, M, Bardelmeijer, H A, Rosing, H, Koopman, F J, Schot, M E, Huinink, W W Ten Bokkel, Beijnen, J H
Publicado 2001

Human mass balance study and metabolite profiling of (14)C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer

por van Andel, Lotte, Zhang, Z., Lu, S., Kansra, V., Agarwal, S., Hughes, L., Tibben, M. M., Gebretensae, A., Lucas, L., Hillebrand, M. J. X., Rosing, H., Schellens, J. H. M., Beijnen, J. H.
Publicado 2017

A phase I and pharmacokinetic study of intraperitoneal topotecan

por Hofstra, L S, Bos, A M E, Vries, E G E de, Zee, A G J van der, Beijnen, J H, Rosing, H, Mulder, N H, Aalders, J G, Willemse, P H B
Publicado 2001

A real or apparent decrease in glomerular filtration rate in patients using olaparib?

por Bruin, M. A. C., Korse, C. M., van Wijnen, B., de Jong, V. M. T., Linn, S. C., van Triest, B., Rosing, H., Beijnen, J. H., van den Broek, D., Huitema, A. D. R.
Publicado 2020

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks

por Kerbusch, T, Groenewegen, G, Mathôt, R A A, Herben, V M M, ten Bokkel Huinink, W W, Swart, M, Ambaum, B, Rosing, H, Jansen, S, Voest, E E, Beijnen, J H, Schellens, J H M
Publicado 2004

A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin

por Schoemaker, N E, van Kesteren, C, Rosing, H, Jansen, S, Swart, M, Lieverst, J, Fraier, D, Breda, M, Pellizzoni, C, Spinelli, R, Porro, M Grazia, Beijnen, J H, Schellens, J H M, ten Bokkel Huinink, WW
Publicado 2002

Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer

por van der Noll, R., Smit, W. M., Wymenga, A. N. M., Boss, D. S., Grob, M., Huitema, A. D. R., Rosing, H., Tibben, M. M., Keessen, M., Rehorst, H., Beijnen, J. H., Schellens, J. H. M.
Publicado 2015